tiprankstipranks
Trending News
More News >
Molecular Partners AG (MLLCF)
OTHER OTC:MLLCF
US Market
Advertisement

Molecular Partners AG (MLLCF) Technical Analysis

Compare
11 Followers

Technical Sentiment

Overall Consensus
Buy
9Bullish
2Neutral
7Bearish
Technical Analysis Consensus
Strong Buy
4Bullish
2Neutral
0Bearish
Moving Average Consensus
Sell
5Bullish
0Neutral
7Bearish
Molecular Partners AG’s (MLLCF) Moving Averages Convergence Divergence (MACD) indicator is <0.01, suggesting Molecular Partners AG is a Buy.
Molecular Partners AG’s (MLLCF) 20-Day exponential moving average is 3.59, while Molecular Partners AG’s (MLLCF) share price is $3.6, making it a Buy.
Molecular Partners AG’s (MLLCF) 50-Day exponential moving average is 3.63, while Molecular Partners AG’s (MLLCF) share price is $3.6, making it a Sell.

Molecular Partners AG (MLLCF) Pivot Points

Dec 04, 2025, 05:25 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
3.60
3.60
3.60
3.60
3.60
3.60
3.60
Fibonacci
3.60
3.60
3.60
3.60
3.60
3.60
3.60
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Molecular Partners AG (MLLCF) Moving Averages

Dec 04, 2025, 05:25 PM
Period
Simple
Exponential
MA5
3.60Sell
3.60Buy
MA10
3.60Sell
3.60Buy
MA20
3.60Buy
3.59Buy
MA50
3.55Buy
3.63Sell
MA100
3.81Sell
3.77Sell
MA200
4.10Sell
4.06Sell
Molecular Partners AG’s (MLLCF) 10-Day exponential moving average is 3.60, while Molecular Partners AG’s (MLLCF) share price is $3.6, making it a Buy.
Molecular Partners AG’s (MLLCF) 100-Day exponential moving average is 3.77, while Molecular Partners AG’s (MLLCF) share price is $3.6, making it a Sell.
Molecular Partners AG’s (MLLCF) stock price is $3.6 and Molecular Partners AG’s (MLLCF) 50-day simple moving average is 3.55, creating a Buy signal.
Molecular Partners AG’s (MLLCF) stock price is $3.6 and Molecular Partners AG’s (MLLCF) 100-day simple moving average is 3.81, creating a Sell signal.
Molecular Partners AG’s (MLLCF) stock price is $3.6 and Molecular Partners AG’s (MLLCF) 200-day simple moving average is 4.10, creating a Sell signal.

Molecular Partners AG (MLLCF) Technical Indicators

Dec 04, 2025, 05:25 PM
Name
Value
Implied Action
RSI (14)
62.67
Neutral
STOCH (9,6)
<0.01
Buy
STOCHRSI (14)
>-0.01
Buy
MACD (12,26)
<0.01
Buy
ADX (14)
32.34
Neutral
CCI (14)
0.00
Neutral
ATR (14)
<0.01
-
ROC
0.00
Buy
Bull/Bear Power (13)
<0.01
Buy
Molecular Partners AG’s (MLLCF) Relative Strength Index (RSI) is 62.67, creating a Neutral signal.
Molecular Partners AG’s (MLLCF) Trend Strength Indicator (ADX) is 32.34, creating a Neutral signal.

FAQ

Is MLLCF a Buy, Hold, or Sell?
Based on MLLCF’s technical indicators, MLLCF is a Buy.
    What is MLLCF’s RSI (14)?
    MLLCF’s RSI (14) is 62.67, which suggests MLLCF is a Neutral.
      What is MLLCF’s MACD?
      MLLCF’s MACD is <0.01, which suggests MLLCF is a Buy.
        What is MLLCF’s 5-day moving average?
        MLLCF’s 5-day moving average is 3.60, which suggests MLLCF is a Sell.
          What is MLLCF’s 20-day moving average?
          MLLCF 20-day moving average is 3.60, which suggests MLLCF is a Buy.
            What is MLLCF’s 50-day moving average?
            MLLCF’s 50-day moving average is 3.55, which suggests MLLCF is a Buy.
              What is MLLCF’s 200-day moving average?
              MLLCF’s 200-day moving average is 4.10, which suggests MLLCF is a Sell.
                What is MLLCF’s Williams % R (14)?
                Currently, no data Available
                What is MLLCF’s CCI (14)?
                MLLCF’s CCI (14) is 0.00, which suggests MLLCF is a Neutral.
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis